153 related articles for article (PubMed ID: 15003475)
1. Differential expression of CD44 in canine melanocytic tumours.
Serra M; Rabanal RM; Miquel L; Domenzain C; Bassols A
J Comp Pathol; 2004; 130(2-3):171-80. PubMed ID: 15003475
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of versican and hyaluronan in melanocytic tumors of dogs.
Docampo MJ; Rabanal RM; Miquel-Serra L; Hernández D; Domenzain C; Bassols A
Am J Vet Res; 2007 Dec; 68(12):1376-85. PubMed ID: 18052744
[TBL] [Abstract][Full Text] [Related]
3. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion.
Mukaratirwa S; van Ederen AM; Gruys E; Nederbragt H
J Comp Pathol; 2004 Nov; 131(4):259-70. PubMed ID: 15511534
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells.
Evanko SP; Johnson PY; Braun KR; Underhill CB; Dudhia J; Wight TN
Arch Biochem Biophys; 2001 Oct; 394(1):29-38. PubMed ID: 11566024
[TBL] [Abstract][Full Text] [Related]
6. Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior.
Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Bassols A
Int J Mol Med; 2011 Feb; 27(2):269-75. PubMed ID: 21136024
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
Sviatoha V; Tani E; Kleina R; Sperga M; Skoog L
Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890
[TBL] [Abstract][Full Text] [Related]
8. Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion.
Edward M; Gillan C; Micha D; Tammi RH
Carcinogenesis; 2005 Jul; 26(7):1215-23. PubMed ID: 15746159
[TBL] [Abstract][Full Text] [Related]
9. V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential.
Serra M; Miquel L; Domenzain C; Docampo MJ; Fabra A; Wight TN; Bassols A
Int J Cancer; 2005 May; 114(6):879-86. PubMed ID: 15645431
[TBL] [Abstract][Full Text] [Related]
10. Effect of transforming growth factor-beta1, insulin-like growth factor-I, and hepatocyte growth factor on proteoglycan production and regulation in canine melanoma cell lines.
Serra M; Pastor J; Domenzain C; Bassols A
Am J Vet Res; 2002 Aug; 63(8):1151-8. PubMed ID: 12171170
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis.
Nasreen N; Mohammed KA; Hardwick J; Van Horn RD; Sanders K; Kathuria H; Loghmani F; Antony VB
Oncol Res; 2002; 13(2):71-8. PubMed ID: 12392154
[TBL] [Abstract][Full Text] [Related]
14. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
Touab M; Arumi-Uría M; Barranco C; Bassols A
Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
[TBL] [Abstract][Full Text] [Related]
15. Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis.
Pirinen R; Leinonen T; Böhm J; Johansson R; Ropponen K; Kumpulainen E; Kosma VM
Hum Pathol; 2005 Jan; 36(1):44-50. PubMed ID: 15712181
[TBL] [Abstract][Full Text] [Related]
16. Versican is differentially expressed in human melanoma and may play a role in tumor development.
Touab M; Villena J; Barranco C; Arumí-Uría M; Bassols A
Am J Pathol; 2002 Feb; 160(2):549-57. PubMed ID: 11839575
[TBL] [Abstract][Full Text] [Related]
17. Spatial distribution of CD44 and hyaluronan in the proximal tibia of the growing rat.
Noonan KJ; Stevens JW; Tammi R; Tammi M; Hernandez JA; Midura RJ
J Orthop Res; 1996 Jul; 14(4):573-81. PubMed ID: 8764866
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 in canine mammary tumours.
Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the canine melanoma antigen recognized by the murine monoclonal antibody IBF9 and its distribution in cultured canine melanoma cell lines.
Oliver JL; Wolfe LG; Lopez MK; Church-Bird A; Toivio-Kinnucan M; Dietrich MA
Am J Vet Res; 1997 Jan; 58(1):46-52. PubMed ID: 8989495
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
